SIRT1 activation by resveratrol ameliorates cisplatin-induced renal injury through deacetylation of p53

被引:155
作者
Kim, Duk Hoon [1 ]
Jung, Yu Jin [1 ]
Lee, Jung Eun [1 ]
Lee, Ae Sin [1 ]
Kang, Kyung Pyo [1 ,4 ]
Lee, Sik [1 ,4 ]
Park, Sung Kwang [1 ,4 ]
Han, Myung Kwan [2 ]
Lee, Sang Yong [3 ]
Ramkumar, Kunga Mohan [1 ]
Sung, Mi Jeong [5 ]
Kim, Won [1 ,4 ]
机构
[1] Chonbuk Natl Univ, Sch Med, Dept Internal Med, Jeonju 560180, South Korea
[2] Chonbuk Natl Univ, Sch Med, Dept Microbiol, Jeonju 560180, South Korea
[3] Chonbuk Natl Univ, Sch Med, Dept Diagnost Radiol, Jeonju 560180, South Korea
[4] Chonbuk Natl Univ, Sch Med, Inst Med Sci, Jeonju 560180, South Korea
[5] Korea Food Res Inst, Food Funct Res Div, Songnam, South Korea
关键词
apoptosis; cisplatin nephrotoxicity; ACUTE KIDNEY INJURY; NF-KAPPA-B; TRAIL-INDUCED APOPTOSIS; HISTONE DEACETYLASE; CELL APOPTOSIS; ACETYLATION; INHIBITORS; PROTECTS; ALPHA; SENSITIZATION;
D O I
10.1152/ajprenal.00258.2010
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
Kim DH, Jung YJ, Lee JE, Lee AS, Kang KP, Lee S, Park SK, Han MK, Lee SY, Ramkumar KM, Sung MJ, Kim W. SIRT1 activation by resveratrol ameliorates cisplatin-induced renal injury through deacetylation of p53. Am J Physiol Renal Physiol 301: F427-F435, 2011. First published May 18, 2011; doi: 10.1152/ajprenal.00258.2010.-Nephrotoxicity is one of the important dose-limiting factors during cisplatin treatment. There is a growing body of evidence that activation of p53 has a critical role in cisplatin-induced renal apoptotic injury. The nicotinamide adenine dinucleotide-dependent protein deacetylase SIRT1 decreases apoptosis through deacetylating of p53, and resveratrol is known as an activator of SIRT1. To study the role of SIRT1 in cisplatin-induced renal injury through interaction with p53, mouse proximal tubular cells (MPT) were treated with cisplatin and examined the expression level of SIRT1, acetylation of p53, PUMA-alpha, Bax, the cytosolic/mitochondrial cytochrome c ratio, and active caspase-3. The expression of SIRT1 was decreased by cisplatin. Resveratrol, a SIRT1 activator, ameliorated cisplatin-induced acetylation of p53, apoptosis, and cytotoxicity in MPT cells. In addition, resveratrol remarkably blocked cisplatin-induced decrease of Bcl-xL in MPT cells. Further specific SIRT1 inhibition with EX 527 or small interference RNA specific to SIRT1 reversed the effect of resveratrol on cisplatin-induced toxicity. Inhibition of p53 by pifithrin-alpha reversed the effect of EX527 in protein expression of PUMA-alpha, Bcl-xL, and caspase-3 and cytotoxicity in MPT cells. SIRT1 protein expression after cisplatin treatment was significantly decreased in the kidney. SIRT1 activation by resveratrol decreased cisplatin-induced apoptosis while improving the glomerular filtration rate. Taken together, our findings suggest that the modulation of p53 by SIRT1 could be a possible target to attenuate cisplatin-induced kidney injury.
引用
收藏
页码:F427 / F435
页数:9
相关论文
共 33 条
[11]   P53 mediates the apoptotic response to GTP depletion after renal ischemia-reperfusion: Protective role of a p53 inhibitor [J].
Kelly, KJ ;
Plotkin, Z ;
Vulgamott, SL ;
Dagher, PC .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2003, 14 (01) :128-138
[12]   SIRT1 deacetylase protects against neurodegeneration in models for Alzheimer's disease and amyotrophic lateral sclerosis [J].
Kim, Dohoon ;
Nguyen, Minh Dang ;
Dobbin, Matthew M. ;
Fischer, Andre ;
Sananbenesi, Farahnaz ;
Rodgers, Joseph T. ;
Delalle, Ivana ;
Baur, Joseph A. ;
Sui, Guangchao ;
Armour, Sean M. ;
Puigserver, Pere ;
Sinclair, David A. ;
Tsai, Li-Huei .
EMBO JOURNAL, 2007, 26 (13) :3169-3179
[13]   COMP-Angiopoietin-1 decreases lipopolysaccharide-induced acute kidney injury [J].
Kim, Duk Hoon ;
Jung, Yu Jin ;
Lee, Ae Sin ;
Lee, Sik ;
Kang, Kyung Pyo ;
Lee, Tae Hwan ;
Lee, Sang Yong ;
Jang, Kyu Yun ;
Moon, Woo Sung ;
Choi, Kyu-Sil ;
Yoon, Kwon-Ha ;
Sung, Mi Jeong ;
Park, Sung Kwang ;
Kim, Won .
KIDNEY INTERNATIONAL, 2009, 76 (11) :1180-1191
[14]   NF-κB-independent sensitization of glioblastoma cells for TRAIL-induced apoptosis by proteasome inhibition [J].
La Ferla-Bruehl, K. ;
Westhoff, M. A. ;
Karl, S. ;
Kasperczyk, H. ;
Zwacka, R. M. ;
Debatin, K. M. ;
Fulda, S. .
ONCOGENE, 2007, 26 (04) :571-582
[15]   Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1α [J].
Lagouge, Marie ;
Argmann, Carmen ;
Gerhart-Hines, Zachary ;
Meziane, Hamid ;
Lerin, Carles ;
Daussin, Frederic ;
Messadeq, Nadia ;
Milne, Jill ;
Lambert, Philip ;
Elliott, Peter ;
Geny, Bernard ;
Laakso, Markku ;
Puigserver, Pere ;
Auwerx, Johan .
CELL, 2006, 127 (06) :1109-1122
[16]   Epigallocatechin-3-O-gallate Decreases Tumor Necrosis Factor-α-induced Fractalkine Expression in Endothelial Cells by Suppressing NF-κB [J].
Lee, Ae Sin ;
Jung, Yu Jin ;
Kim, Duk Hoon ;
Lee, Tae Hwan ;
Kang, Kyung Pyo ;
Lee, Sik ;
Lee, Nae Ho ;
Sung, Mi Jeong ;
Kwon, Dae Young ;
Park, Sung Kwang ;
Kim, Won .
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY, 2009, 24 (5-6) :503-510
[17]   Mechanisms of death induced by cisplatin in proximal tubular epithelial cells: Apoptosis vs. necrosis [J].
Lieberthal, W ;
Triaca, V ;
Levine, J .
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL FLUID AND ELECTROLYTE PHYSIOLOGY, 1996, 270 (04) :F700-F708
[18]   Negative control of p53 by Sir2α promotes cell survival under stress [J].
Luo, JY ;
Nikolaev, AY ;
Imai, S ;
Chen, DL ;
Su, F ;
Shiloh, A ;
Guarente, L ;
Gu, W .
CELL, 2001, 107 (02) :137-148
[19]   Acetylation of p53 augments its site-specific DNA binding both in vitro and in vivo [J].
Luo, JY ;
Li, MY ;
Tang, Y ;
Laszkowska, M ;
Roeder, RG ;
Gu, W .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (08) :2259-2264
[20]   Histone Deacetylase Inhibitors Current Status and Overview of Recent Clinical Trials [J].
Ma, Xujun ;
Ezzeldin, Hany H. ;
Diasio, Robert B. .
DRUGS, 2009, 69 (14) :1911-1934